Prostate drug can extend patients' life

A GROUND-BREAKING treatment for prostate cancer which extends the lives of men with late-stage disease could be available in the UK within a year.

Regulators have been asked to approve the pill, abiraterone acetate, which offers men with few other treatment options an average of four months of extra life.